Travere Therapeutics Inc
TVTXLatest QuantConomy context for TVTX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Travere Therapeutics Inc
QuantConomy has a structured record for TVTX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- TVTX
- Name
- Travere Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq openfigi
Recent signals for TVTX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 12, 12:00 AM | TVTX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Feb 19, 12:00 AM | TVTX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-19. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| executive change | neutral | 75 | Jun 16, 08:40 PM | TVTX filed 8-K: Director or Officer Changes - 1 material event - [strong neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| TVTX | NASDAQ | alpaca | Travere Therapeutics, Inc. Common Stock |
| TVTX | NASDAQ | alphavantage | Travere Therapeutics Inc |
| TVTX | NASDAQ | fmp | Travere Therapeutics, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | gift | 468 | $0.00 | $0 | 4 on EDGAR |
| Jun 12, 2026 | Coughlin Timothy | Director | exercise | 10,000 | $26.52 | $265,200 | 4 on EDGAR |
| May 19, 2026 | LYONS GARY A | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Poole Sandra | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Williams Brinkley Ruth | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Squarer Ron | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Bruhn Suzanne Louise | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Baynes Roy D. | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Coughlin Timothy | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Meckler Jeffrey A | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 19, 2026 | Orwin John A | Director | grant | 4,000 | $0.00 | $0 | 4 on EDGAR |
| May 15, 2026 | Coughlin Timothy | Director | sale | 3,250 | $43.49 | $141,343 | 4 on EDGAR |
| May 5, 2026 | Baynes Roy D. | Director | exercise | 4,500 | $18.27 | $82,215 | 4 on EDGAR |
| May 4, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | exercise | 4,250 | $0.00 | $0 | 4 on EDGAR |
| May 4, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | exercise | 22,500 | $0.00 | $0 | 4 on EDGAR |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | exercise | 20,000 | $22.40 | $448,000 | 4 on EDGAR |
| May 4, 2026 | Meckler Jeffrey A | Director | exercise | 8,000 | $16.33 | $130,640 | 4 on EDGAR |
| May 4, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | exercise | 4,250 | $0.00 | $0 | 4 on EDGAR |
| May 4, 2026 | ROTE WILLIAM E. | Chief Research Officer | exercise | 4,250 | $0.00 | $0 | 4 on EDGAR |
| May 4, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | exercise | 20,000 | $17.96 | $359,200 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query TVTX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access